Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;80(6):2665-74.
doi: 10.1128/JVI.80.6.2665-2674.2006.

Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion

Michele Di Mascio  1 , Irini Sereti, Lynn T Matthews, Ven Natarajan, Joseph Adelsberger, Richard Lempicki, Christian Yoder, Elizabeth Jones, Catherine Chow, Julia A Metcalf, Igor A Sidorov, Dimiter S Dimitrov, Michael A Polis, Joseph A Kovacs
Affiliations

Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion

Michele Di Mascio et al. J Virol. 2006 Mar.

Abstract

Both naïve CD4+ and naïve CD8+ T cells are depleted in individuals with human immunodeficiency virus type 1 (HIV-1) infection by unknown mechanisms. Analysis of their dynamics prior to and after highly active antiretroviral therapy (HAART) could reveal possible mechanisms of depletion. Twenty patients were evaluated with immunophenotyping, intracellular Ki67 staining, T-cell receptor excision circle (TREC) quantitation in sorted CD4 and CD8 cells, and thymic computed tomography scans prior to and approximately 6 and approximately 18 months after initiation of HAART. Naïve T-cell proliferation decreased significantly during the first 6 months of therapy (P < 0.01) followed by a slower decline. Thymic indices did not change significantly over time. At baseline, naïve CD4+ T-cell numbers were lower than naive CD8+ T-cell numbers; after HAART, a greater increase in naïve CD4+ T cells than naïve CD8+ T cells was observed. A greater relative change (n-fold) in the number of TREC+ T cells/mul than in naïve T-cell counts was observed at 6 months for both CD4+ (median relative change [n-fold] of 2.2 and 1.7, respectively; P < 0.01) and CD8+ T cell pools (1.4 and 1.2; P < 0.01). A more pronounced decrease in the proliferation than the disappearance rate of naïve T cells after HAART was observed in a second group of six HIV-1-infected patients studied by in vivo pulse labeling with bromodeoxyuridine. These observations are consistent with a mathematical model where the HIV-1-induced increase in proliferation of naïve T cells is mostly explained by a faster recruitment into memory cells.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Naïve T-cell counts, TRECs per microliter of blood, and fraction of TREC+ T cells per 106 naïve T cells for CD4 and CD8+ T cells at the three time points of the study. Values are the means ± standard errors of the means. *, P < 0.05; **, P < 0.01 (versus time point 0).
FIG. 2.
FIG. 2.
(A) Diagram of the model used to describe the changes in naïve T-cell counts and TREC+ T cells/μl during HIV infection and after initiation of HAART. The proliferation rate of naïve T cells is increased during HIV-1 infection by a factor Ω as a result of the increase in the rate of priming into memory cells. (B) HAART-induced changes in the fraction of TREC+ T cells per naïve T cell (left) and TREC+ cells/μl and naïve T-cell counts (right) predicted by a model that assumes that the HIV-1-induced increase in proliferation of naïve T cells is largely explained by the increase in rate of priming: formula image= σ + [p + Ω(t)]T − [δA + δR + Ω(t)]T and formula image= fσ − [δA + δR + Ω(t)]T+, where σ = 1 cell · μl−1 · day−1, f = 0.1, p = 0.01 day−1, and d = δA + δR = 0.03 day−1. Here, Ω(t) is modeled as a single exponential decaying function from the administration of HAART: Ω(t) = Ω0e−λt, with Ω0 = 0.02 day−1 and λ = 0.05 day−1. The graphs show the ratio of the value of the individual parameters at time t to the value at time zero. The dynamics predicted by this model are similar to the dynamics observed for CD8+ naïve T cells in this study. (C) HAART-induced changes for the same variables when the death rate, δR, is also enhanced by a factor Ψ(t) during chronic HIV-1 infection due to activation-induced cell death. Here, Ψ(t) is modeled as a single exponential decaying function from the administration of HAART: Ψ(t) = Ψ0e−γt, with Ψ0 = 0.025 day−1 and γ = 0.005 day−1. Other parameters are as follows: Ω0 = 0.045 day−1, λ = 0.05 day−1, σ = 1 cell · μl−1 · day−1, f = 0.1, p = 0.01 day−1, and d = δA + δR = 0.02 day−1. The dynamics predicted by this model are similar to the dynamics observed for CD4+ naïve T cells in this study.
FIG. 3.
FIG. 3.
Comparison of experimental data with modeling of the kinetics of BrdU incorporation and decay by CD4+ naïve T cells for each patient. Lines represent the modeling, and symbols represent the actual data points (red, pre-HAART; blue, post-HAART).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arron, S. T., R. M. Ribeiro, A. Gettie, R. Bohm, J. Blanchard, J. Yu, A. S. Perelson, D. D. Ho, and L. Zhang. 2005. Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus. Eur. J. Immunol. 35:46-55. - PubMed
    1. Davey, R. T., Jr., N. Bhat, C. Yoder, T. W. Chun, J. A. Metcalf, R. Dewar, V. Natarajan, R. A. Lempicki, J. W. Adelsberger, K. D. Miller, J. A. Kovacs, M. A. Polis, R. E. Walker, J. Falloon, H. Masur, D. Gee, M. Baseler, D. S. Dimitrov, A. S. Fauci, and H. C. Lane. 1999. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. USA 96:15109-15114. - PMC - PubMed
    1. Davey, R. T., Jr., R. L. Murphy, F. M. Graziano, S. L. Boswell, A. T. Pavia, M. Cancio, J. P. Nadler, D. G. Chaitt, R. L. Dewar, D. K. Sahner, A. M. Duliege, W. B. Capra, W. P. Leong, M. A. Giedlin, H. C. Lane, and J. O. Kahn. 2000. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. JAMA 284:183-189. - PubMed
    1. Debacq, C., B. Asquith, P. Kerkhofs, D. Portetelle, A. Burny, R. Kettmann, and L. Willems. 2002. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc. Natl. Acad. Sci. USA 99:10048-10053. - PMC - PubMed
    1. De Boer, R. J., H. Mohri, D. D. Ho, and A. S. Perelson. 2003. Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques. J. Immunol. 170:2479-2487. - PubMed

Publication types

Substances